We are live on
!
Find out more
HCM
Hillman Capital Management Portfolio holdings
AUM
$138M
1-Year Est. Return
8.57%
This Fund
S&P 500
This Quarter
Est. Return
+3.43%
1 Year Est. Return
+8.57%
3 Year Est. Return
+20.19%
5 Year Est. Return
+18.79%
10 Year Est. Return
–
AUM
$183M
AUM Growth
-$20M
(-9.8%)
Cap. Flow
-$21.4M
Cap. Flow
% of AUM
-11.7%
Top 10 Holdings %
Top 10 Hldgs %
35.07%
Holding
52
New
1
Increased
12
Reduced
36
Closed
2
Avg Time Held
13
quarters
Top 10 Avg Time Held
1.4
quarters
Top 20 Avg Time Held
7.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$2.65M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$334K |
| 3 |
Akamai
AKAM
|
+$322K |
| 4 |
The Kraft Heinz Company
KHC
|
+$131K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$102K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Union
WU
|
+$3.91M |
| 2 |
Microchip Technology
MCHP
|
+$1.47M |
| 3 |
Microsoft
MSFT
|
+$1.32M |
| 4 |
Walt Disney
DIS
|
+$1.2M |
| 5 |
Boeing
BA
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.97% |
| 2 | Consumer Staples | 20.47% |
| 3 | Technology | 16.44% |
| 4 | Communication Services | 15.05% |
| 5 | Materials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
AT&T
T
$166B
| $6.83M | 3.72% |
235,864
-27,909
| -11% | -$769K |
2013 Q3
47 quarters
|
|
2
Warner Bros
WBD
$77.6B
| $6.82M | 3.72% |
595,547
-62,487
| -9% | -$583K |
2021 Q2
16 quarters
|
|
|
3
Boeing
BA
$152B
| $6.62M | 3.61% |
31,577
-5,961
| -16% | -$1.13M |
2020 Q2
20 quarters
|
|
4
Estee Lauder
EL
$33.8B
| $6.59M | 3.6% |
81,599
-13,675
| -14% | -$880K |
2023 Q4
6 quarters
|
|
|
5
Microsoft
MSFT
$3.9T
| $6.51M | 3.55% |
13,095
-3,050
| -19% | -$1.32M |
2013 Q2
48 quarters
|
|
6
Nike
NKE
$50.4B
| $6.45M | 3.52% |
90,843
-2,168
| -2% | -$130K |
2024 Q1
5 quarters
|
|
7
CVS Health
CVS
$111B
| $6.41M | 3.5% |
92,997
-7,453
| -7% | -$489K |
2019 Q4
22 quarters
|
|
8
ASML
ASML
$714B
| $6.18M | 3.37% |
7,716
-1,561
| -17% | -$1.12M |
2024 Q4
2 quarters
|
|
9
AB InBev
BUD
$147B
| $5.99M | 3.27% |
87,093
-16,757
| -16% | -$1.13M |
2019 Q4
22 quarters
|
|
10
GSK
GSK
$93.3B
| $5.86M | 3.2% |
152,599
-12,544
| -8% | -$479K |
2020 Q4
18 quarters
|
|
11
Pfizer
PFE
$156B
| $5.69M | 3.1% |
234,628
-6,953
| -3% | -$162K |
2023 Q4
6 quarters
|
|
12
DuPont de Nemours
DD
$17.6B
| $5.64M | 3.08% |
65,504
-1,211
| -2% | -$101K |
2019 Q4
22 quarters
|
|
13
International Flavors & Fragrances
IFF
$21.2B
| $5.49M | 3% |
74,680
-6,093
| -8% | -$460K |
2023 Q2
8 quarters
|
|
|
14
The Kraft Heinz Company
KHC
$25.9B
| $5.42M | 2.96% |
209,731
+4,733
| +2% | +$131K |
2019 Q4
22 quarters
|
|
15
Baxter International
BAX
$12.5B
| $5.4M | 2.95% |
178,429
-3,583
| -2% | -$109K |
2023 Q3
7 quarters
|
|
16
CarMax
KMX
$7.79B
| $5.35M | 2.92% |
79,610
-4,491
| -5% | -$302K |
2022 Q2
12 quarters
|
|
17
Biogen
BIIB
$33B
| $5.27M | 2.88% |
41,972
-2,053
| -5% | -$256K |
2019 Q4
22 quarters
|
|
18
Zimmer Biomet
ZBH
$17.5B
| $5.07M | 2.77% |
55,598
-2,959
| -5% | -$286K |
2021 Q3
15 quarters
|
|
19
Brown-Forman Class B
BF.B
$12.1B
| $4.73M | 2.58% |
175,788
-14,491
| -8% | -$465K |
2024 Q4
2 quarters
|
|
20
T. Rowe Price
TROW
$22.2B
| $3.7M | 2.02% |
38,294
-2,627
| -6% | -$241K |
2022 Q1
13 quarters
|
|
|
21
TSMC
TSM
$2.52T
| $3.65M | 1.99% |
16,099
+14,295
| +792% | +$2.65M |
2024 Q3
3 quarters
|
|
|
22
Walt Disney
DIS
$179B
| $3.57M | 1.95% |
28,762
-11,548
| -29% | -$1.2M |
2022 Q4
10 quarters
|
|
23
Comcast
CMCSA
$76.5B
| $3.54M | 1.93% |
99,263
-9,312
| -9% | -$322K |
2020 Q4
18 quarters
|
|
|
24
Microchip Technology
MCHP
$44.2B
| $3.49M | 1.9% |
49,536
-26,817
| -35% | -$1.47M |
2024 Q4
2 quarters
|
|
25
Nucor
NUE
$57B
| $3.48M | 1.9% |
26,829
-3,836
| -13% | -$448K |
2024 Q3
3 quarters
|
|
Similar funds
PA
WA
EWP
FFG
AA
SWM
GI
ACM
Hillman Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Hillman Capital Management held 52 positions worth $183M, down 9.8% from $203M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Hillman Capital Management withdrew a net $21.4M in Q2 2025, closing 2 positions and reducing 36 holdings. Its most notable exit was Western Union, an estimated $3.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Hillman Capital Management opened a new position in Akamai worth $331K.
- Hillman Capital Management's largest Q2 2025 buy was Akamai: 4,149 shares worth $331K.
- Hillman Capital Management added most to TSMC in Q2 2025, an estimated $2.65M increase.
- Hillman Capital Management's biggest Q2 2025 reduction was Microchip Technology, cutting an estimated $1.47M.
- Hillman Capital Management fully exited Western Union in Q2 2025, selling an estimated $3.91M.
- Hillman Capital Management's ten largest holdings make up 35% of its $183M portfolio in Q2 2025.
- Hillman Capital Management opened 1 new position and closed 2 in Q2 2025.
- Hillman Capital Management's portfolio value fell 9.8% quarter-over-quarter to $183M.
Based on Hillman Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.